每年專案
個人檔案
學歷
- 1998 美國麻省藥學院藥學博士
- 1996 美國麻省藥學院藥學碩士
- 1991 中國醫藥學院藥學系學士
經歷
- 2016- 臺北醫學大學臨床藥學學科教授
- 2016-2017 臺北醫學大學生技醫療產業研發博士學位學程副教授
- 2012-2016 臺北醫學大學臨床藥學學科副教授
- 2008-2012 臺北醫學大學藥學系副教授
- 2002-2008 臺北醫學大學藥學系助理教授
研究興趣
- 藥物與中草藥新活性探索
- 營養素對疾病預防或治療成效之生化影響
- 臨床藥效分析與療效藥物濃度監測
指紋
查看啟用 Tzu-Hua Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 13 已完成
-
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y. A., Wu, T. H., Chen, C. H. & Lu, M. L., 7月 1 2022, 於: International journal of molecular sciences. 23, 13, 7092.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
開啟存取6 引文 斯高帕斯（Scopus） -
Developing a Sensitive Platform to Measure 5-Methyltetrahydrofolate in Subjects with MTHFR and PON1 Gene Polymorphisms
Lu, M. L., Ku, W. C., Syifa, N., Hu, S. C., Chou, C. T., Wu, Y. H., Kuo, P. H., Chen, C. H., Chen, W. J. & Wu, T. H., 8月 2022, 於: Nutrients. 14, 16, 3320.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取2 引文 斯高帕斯（Scopus） -
Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials
Goh, K. K., Chen, C. H., Wu, T. H., Chiu, Y. H. & Lu, M. L., 8月 22 2022, 於: Frontiers in Pharmacology. 13, 944437.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Goh, K. K., Wu, T. H., Chen, C. H. & Lu, M. L., 1月 2021, 於: Journal of Psychopharmacology. 35, 3, p. 236-252 17 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
17 引文 斯高帕斯（Scopus） -
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
Wu, T. H., Lin, C. H., Goh, K. K., Chen, C. Y. A., Chen, C. H., Lane, H. Y. & Lu, M. L., 8月 5 2021, 於: Frontiers in Pharmacology. 12, 718800.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取5 引文 斯高帕斯（Scopus）
資料集
-
MOESM1 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Wu, C. (Contributor), Chen, Y. (Contributor), Chen, C. (Contributor), Chien, S. (Contributor), Syifa, N. (Contributor), Hung, Y. (Creator), Cheng, K. (Contributor), Hu, S. (Creator), Lo, P. (Contributor), Lin, S. (Contributor) & Wu, T. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293073.v1, https://springernature.figshare.com/articles/MOESM1_of_Constructing_a_bilingual_website_with_validated_database_for_Herb_and_Western_medicine_interactions_using_Ginseng_Ginkgo_and_Dong_Quai_as_examples/11293073/1
資料集: Dataset
-
MOESM2 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Chien, S. (Contributor), Wu, C. (Contributor), Hung, Y. (Creator), Cheng, K. (Contributor), Wu, T. (Contributor), Syifa, N. (Contributor), Lo, P. (Contributor), Lin, S. (Contributor), Hu, S. (Creator), Chen, Y. (Contributor) & Chen, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293076.v1, https://doi.org/10.6084%2Fm9.figshare.11293076.v1
資料集: Dataset
-
sj-pdf-1-jop-10.1177_0269881120965937 – Supplemental material for Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Wu, T. (Contributor), Lu, M. (Contributor), Chen, C. (Contributor) & Goh, K. K. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.13547384.v1, https://doi.org/10.25384%2Fsage.13547384.v1
資料集: Dataset
-
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Goh, K. K. (Contributor), Wu, T. (Contributor), Chen, C. (Contributor) & Lu, M. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.c.5262416.v1, https://sage.figshare.com/collections/Efficacy_of_i_N_i_-methyl-_i_D_i_-aspartate_receptor_modulator_augmentation_in_schizophrenia_A_meta-analysis_of_randomised_placebo-controlled_trials/5262416/1
資料集: Dataset